UPDATE: Neuraxpharm, a leading European specialty pharmaceutical company, has officially launched on the TraceLink network with its new Multienterprise Information Network Tower (MINT) as of December 18, 2025. This critical move aims to revolutionize the company’s supply chain operations by enabling real-time data exchange across its global network of over 291,000 authenticated trading partners.
The urgency of this development stems from the complex challenges Neuraxpharm faced, managing more than 3,000 SKUs across over 100 markets. Fragmented systems and outdated manual processes had been hindering operational efficiency, impacting lead times, and increasing costs. Essential information, including purchase orders and delivery confirmations, was previously exchanged through emails and spreadsheets, creating delays and risking product availability.
With MINT, Neuraxpharm has unified its partner ecosystem, allowing real-time collaboration and seamless data transfer directly between ERP systems. This update dramatically reduces turnaround times for internal demand forecasts, moving from hours to mere minutes. Chief Technology Officer Burghard Burczyk emphasized the importance of this transition, stating, “Product availability and reliable patient supply are our top priorities, and the reliance on manual processes was slowing our ability to act on real-time information.”
This swift integration not only enhances visibility across the supply chain but also supports Neuraxpharm’s future AI-driven forecasting and decision-making initiatives. By establishing a standardized data layer, the company is poised to improve forecast accuracy and automate processes, ensuring that medications reach patients without disruption.
The implementation of TraceLink’s B2N Integrate-OnceTM model has further streamlined partner onboarding. This approach allows partners to connect to the TraceLink network effortlessly and at no cost, eliminating the need for multiple integrations and reducing IT resource strain. Burczyk noted, “For our CMOs and suppliers, participation is effortless and free. This creates long-term value across the entire ecosystem.”
As Neuraxpharm accelerates its path to agentic orchestration, the implications for patient care and operational efficiency are significant. The integration of advanced technologies within the supply chain sets a new standard for the pharmaceutical industry, demonstrating how real-time data can drive better outcomes.
In conclusion, Neuraxpharm’s launch of TraceLink MINT marks a pivotal shift in supply chain management, emphasizing the need for agility and collaboration in today’s fast-paced pharmaceutical landscape. Stakeholders and patients alike can expect improved service quality and an enhanced focus on ensuring that critical medications are consistently available.
Stay tuned for updates as Neuraxpharm continues to innovate and expand its capabilities in the coming months.
